The US Food and Drug Administration has approved a landmark eye drop that uses a combined dose of medication to restore ...
Eventually, you succumb to “trombone arm,” stretching your hands out as far as they will go, until finally, you admit defeat ...
Age-related near vision loss has long been treated as an inevitable annoyance of getting older, a slow erosion of clarity ...
Once-daily carbachol/brimonidine tartrate significantly improves aging-related vision loss ...
The U.S. Food and Drug Administration has approved Yuvezzi (carbachol and brimonidine tartrate) ophthalmic solution 2.75%/0.1 ...
The burden of presbyopia and reading glasses drives patients to look for solutions.“There is a clear and growing patient ...
The FDA has approved the first dual-agent eye drop to treat presbyopia, a condition that causes gradual loss of near vision in adults.
Combining two eye drops that have been on the market for at least 30 years each has earned Tenpoint Therapeutics an FDA ...
The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...